GMS Ventures & Investments (CIK 1804598) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy OTLK (2.5M shares), Buy OTLK (8.5M shares), Buy OTLK (4.3M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 2.5M | $2.5M |
| 2026-06-01 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 8.5M | $5.0M |
| 2025-05-28 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 4.3M | $6.0M |
来源：SEC Form 4 申报文件 · 截至 2026-08-14